MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
$51,550K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Proceeds from maturities of mark...
Prepaid expenses, operating leas...
Share-based compensation
Others
Negative Cash Flow Breakdown
Accrued expenses, tax liability ...
Accounts payable
Net accretion of discounts/premi...
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net income (loss)
43,665
-8,278
-5,852
16,016
Depreciation and amortization
2
3
3
35
Loss on disposal of assets
-18
-
-
-
Net accretion of discounts/premiums on debt securities
-5
-51
-97
-113
Share-based compensation
424
613
774
1,047
Gain on sale of joint venture
-
-
0
22,350
Loss on investment in joint venture
0
0
0
0
Prepaid expenses, operating lease right-of-use assets and other current assets
-2,443
155
-815
773
Accounts payable
-107
814
-143
150
Accrued expenses, tax liability and operating lease liabilities
-521
-712
33
-350
Deferred revenue
0
-212
-212
-212
Net cash provided by (used in) operating activities
45,919
-7,978
-4,679
-6,550
Purchases of marketable securities
0
0
7,075
738
Proceeds from maturities of marketable securities
5,500
17,900
11,000
9,965
Proceeds from sale of common stock received from sale of joint venture
-
-
0
20,000
Investment in joint venture
0
0
0
0
Net cash provided by investing activities
5,500
17,900
3,925
29,227
Proceeds from the issuance of common stock from exercise of stock options
-
3
0
0
Proceeds from the issuance of common stock under the stock purchase plan
13
-
6
10
Payments of offering costs
-
-
0
0
Proceeds from the issuance of common stock from exercise of stock options
121
-
-
-
Net cash provided by financing activities
131
3
6
0
Net increase (decrease) in cash and cash equivalents
51,550
9,925
-748
22,677
Cash and cash equivalents beginning of period
41,299
31,374
32,122
13,903
Cash and cash equivalents end of period
92,849
41,299
31,374
32,122
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Net income (loss)
$43,665K
(328.11%↑ Y/Y)
Prepaid expenses,
operating lease...
-$2,443K
(-217.17%↓ Y/Y)
Proceeds from maturities
of marketable...
$5,500K
(-78.43%↓ Y/Y)
Proceeds from the
issuance of common stock...
$121K
Proceeds from the
issuance of common stock...
$13K
(30.00%↑ Y/Y)
Share-based compensation
$424K
(-87.86%↓ Y/Y)
Loss on disposal of
assets
-$18K
Depreciation and
amortization
$2K
(-96.30%↓ Y/Y)
Net cash provided by
(used in) operating...
$45,919K
(347.09%↑ Y/Y)
Net cash provided by
investing activities
$5,500K
(-61.04%↓ Y/Y)
Net cash provided by
financing activities
$131K
(1210.00%↑ Y/Y)
Canceled cashflow
$633K
Net increase
(decrease) in cash and cash...
$51,550K
(1256.35%↑ Y/Y)
Accrued expenses, tax
liability and operating...
-$521K
(37.38%↑ Y/Y)
Accounts payable
-$107K
(32.70%↑ Y/Y)
Net accretion of
discounts/premiums on debt...
-$5K
(98.62%↑ Y/Y)
Buy us a coffee
Rallybio Corp (RLYB)
Rallybio Corp (RLYB)